No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Weight-loss Drug Battle: Who Are the Latest Players Involved
Analysts' Top Healthcare Picks: Genfit (GNFTF), Ventyx Biosciences (VTYX)
Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX) and Ocugen (OCGN)
LifeSci Capital Maintains Ventyx Biosciences(VTYX.US) With Buy Rating
Ventyx Biosciences GAAP EPS of -$0.41 Beats by $0.12
Ventyx Biosciences | 10-K: FY2024 Annual Report